Policy & Regulation
20 January 2021 - - US-based biotechnology company Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) has closed its underwritten public offering of 7,868,421 shares of its common stock at a public offering pr...
20 January 2021 - - US-based adult stem cell therapies developer BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) is highlighting the peer-reviewed publication of a preclinical study in the ...
20 January 2021 - - The US Food and Drug Administration has accepted its supplemental Biologics License Application for Opdivo (nivolumab), in combination with fluoropyrimidine- and platinum...
20 January 2021 - - The first patient has been dosed in a Phase 1 clinical trial evaluating FT-7051, a selective inhibitor of CBP/p300, a known co-activator of the androgen receptor in men with metast...
20 January 2021 - - US-based Aveo Oncology (NASDAQ: AVEO) has received a commitment letter for an incremental USD 10m loan from Hercules Capital, Inc. (NYSE: HTGC) and its affiliates, to be added to t...
20 January 2021 - UK foreign secretary Dominic Raab has stated that the UK is assisting Kenya to prepare for the roll-out of a COVID-19 vaccine developed by British pharmaceutical company Astrazeneca ...